Suppr超能文献

人类食物过敏的口服耐受诱导

Oral tolerance induction for human food allergy.

作者信息

Noh Geunwoong, Lee Jae Ho

机构信息

Subdivision of Allergy and Clinical Immunology, Department of Paediatrics, Chungnam National University Hospital, Jung-gu, Daejeon, Republic of Korea.

出版信息

Inflamm Allergy Drug Targets. 2012 Apr;11(2):131-42. doi: 10.2174/187152812800392869.

Abstract

Food allergies are classified as IgE-mediated and non-IgE mediated type. The number of successful reports of immunotherapy, namely tolerance induction for food allergy (TIFA) are increasing, bringing hope for meaningful positive and radical treatment of food allergy. Therapeutic characteristics of the clinical course in TIFA for NFA are different from TIFA for IFA. Cytokines including IL-10, TGF-β and IFN-γ and regulatory cells such as Treg and Breg, are involved in immune tolerance. IFN-γ has been used for tolerance induction of food allergy as an immunomodulatory biologics. A definitive distinction between IgE-mediated and non-IgE-mediated food allergies is absolutely essential for diagnostic and therapeutic purposes. Original SOTI using IFN-γ is more effective then conventional SOTI without IFN-γ. Especially, IFN-γ is absolutely necessary for the tolerance induction of NFA. This review highlights and updates the advances in the conceptual immunological background and the clinical characteristics of oral tolerance induction for food allergy.

摘要

食物过敏分为IgE介导型和非IgE介导型。免疫疗法成功的报告数量,即食物过敏耐受性诱导(TIFA)正在增加,为食物过敏的有效积极和根治性治疗带来了希望。非IgE介导的食物过敏(NFA)的TIFA临床过程的治疗特征与IgE介导的食物过敏(IFA)的TIFA不同。包括IL-10、TGF-β和IFN-γ在内的细胞因子以及Treg和Breg等调节细胞参与免疫耐受。IFN-γ已作为一种免疫调节生物制剂用于食物过敏的耐受性诱导。对于诊断和治疗目的而言,明确区分IgE介导和非IgE介导的食物过敏绝对至关重要。使用IFN-γ的原始口服特异性免疫疗法(SOTI)比不使用IFN-γ的传统SOTI更有效。特别是,IFN-γ对于NFA的耐受性诱导绝对必要。本综述重点介绍并更新了食物过敏口服耐受性诱导在概念性免疫背景和临床特征方面的进展。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验